Oxford Science Enterprises
Oxford Science Enterprises (OSE) is an independent investment company and venture builder that transforms cutting-edge research from the University of Oxford into commercial companies tackling global challenges across deep tech, life sciences, and health tech. Operating on a "find, fund, build" model, OSE provides patient capital and hands-on company-building to Oxford science founders, backing 50+ flagship companies with a net asset value of around £1.3bn alongside 300+ co-investors. Notable outcomes include Oxford Ionics (acquired by IonQ) and Dark Blue Therapeutics. This is a company profile in the API Evangelist network; OSE is an investor and venture builder and does not publish a public API or developer program.
Oxford Science Enterprises is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Deep Tech, HealthTech, and Venture Capital.
Oxford Science Enterprises’ developer surface includes engineering blog, support, and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Other 2
Properties that don't map to a standard resource type